Provided by Tiger Trade Technology Pte. Ltd.

AbCellera Biologics

12.50
+1.8917.81%
Post-market: 12.500.00000.00%18:49 EDT
Volume:10.69M
Turnover:129.31M
Market Cap:4.05B
PE:-22.91
High:12.50
Open:11.00
Low:10.99
Close:10.61
52wk High:12.50
52wk Low:2.75
Shares:324.00M
Float Shares:221.00M
Volume Ratio:1.47
T/O Rate:4.83%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5455
EPS(LYR):-0.4902
ROE:-17.30%
ROA:-10.39%
PB:4.52
PE(LYR):-25.50

Loading ...

AbCellera Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Reuters
·
Aug 12

AbCellera Umumkan Penawaran Saham Lanjutan Senilai USD 200 Juta

Reuters
·
Aug 12

Abcellera Biologics - Proceeds to Fund Pipeline Research, Clinical Advancement, and Working Capital

THOMSON REUTERS
·
Aug 12

Abcellera Biologics - Announces $200 Mln Public Offering of Common Shares and Pre-Funded Warrants

THOMSON REUTERS
·
Aug 12

AbCellera Biologics is Maintained at Buy by Truist Securities

Dow Jones
·
Aug 12

Abcellera Biologics Inc. : Truist Securities Raises Target Price to $30 from $12

THOMSON REUTERS
·
Aug 11

Canada's Medexus Q1 Revenue Beats on Grafapex Strength

Reuters
·
Aug 11

AbCellera price target raised to $25 from $13 at JonesResearch

TIPRANKS
·
Aug 11

U.S. Stocks on the MOVE-Microsoft, Coastal Financial

Reuters
·
Aug 11

AbCellera Shares Jump on Trial Results Amid Interest in Menopause Drugs

Dow Jones
·
Aug 10

Sector Update: Healthcare Stocks Edge Higher Premarket Monday

MT Newswires Live
·
Aug 10

Analysts Offer Insights on Healthcare Companies: Novo Nordisk (NVO), Vanda (VNDA) and AbCellera Biologics (ABCL)

TIPRANKS
·
Aug 10

AbCellera Biologics' ABCL635 Meets Primary Efficacy Endpoints in Phase 2 Study

MT Newswires Live
·
Aug 10

U.S. Stocks on the MOVE-Apple, Barrick Mining, AbCellera Biologics

Reuters
·
Aug 10

AbCellera Posts Corporate Overview Highlighting Internal Antibody Pipeline and $565 Million-Plus Cash Position

Reuters
·
Aug 10

This Biotech's Drug Could Treat Hot Flashes. the Stock is up 32% on Good News.

Dow Jones
·
Aug 10

Abcellera Biologics Shares Rise 30.5% Premarket After Experimental Drug Reduces Hot Flashes in Mid-Stage Trial

THOMSON REUTERS
·
Aug 10

AbCellera's Menopause Drug Reduces Hot Flashes in Mid-Stage Trial

Reuters
·
Aug 10

AbCellera Says Phase 2 Trial Shows Abcl635 Cuts Menopausal Hot Flashes After Single Dose

Reuters
·
Aug 10

Abcellera Biologics - Phase 2 Results Show Best-in-Class Reductions in Vasomotor Symptoms After Single Dose

THOMSON REUTERS
·
Aug 10